Opsumit FDA Approval History
FDA Approved: Yes (First approved October 18, 2013)
Brand name: Opsumit
Generic name: macitentan
Dosage form: Tablets
Company: Actelion Pharmaceuticals US, Inc.
Treatment for: Pulmonary Arterial Hypertension
Opsumit (macitentan) is a dual endothelin receptor antagonist for the treatment of patients with pulmonary arterial hypertension.
Development timeline for Opsumit
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.